AbCellera Biologics Inc. ABCL Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s change in AP?
- AbCellera Biologics Inc. (ABCL) reported change in AP of -$9.41M in Q1 2026.
- How has AbCellera Biologics Inc.'s change in AP changed year-over-year?
- AbCellera Biologics Inc.'s change in AP decreased by 175.9% year-over-year, from -$3.41M to -$9.41M.
- What is the long-term trend for AbCellera Biologics Inc.'s change in AP?
- Over 3 years (2022 to 2025), AbCellera Biologics Inc.'s change in AP has grown at a 18.2% compound annual growth rate (CAGR), from -$2.09M to $3.46M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.